Chison Medical Technologies Co., Ltd. (688358.SS)
CNY 28.14
(0.32%)
CNY 28.14
(0.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.52 Billion CNY | 0.57% |
| 2022 | 1.51 Billion CNY | 8.29% |
| 2021 | 1.39 Billion CNY | 3.59% |
| 2020 | 1.34 Billion CNY | 4.58% |
| 2019 | 1.29 Billion CNY | 298.92% |
| 2018 | 323.5 Million CNY | 36.05% |
| 2017 | 237.78 Million CNY | 55.38% |
| 2016 | 153.03 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.59 Billion CNY | 3.75% |
| 2024 Q3 | 1.58 Billion CNY | -0.55% |
| 2024 Q1 | 1.53 Billion CNY | 1.01% |
| 2023 Q4 | 1.52 Billion CNY | 1.77% |
| 2023 FY | 1.52 Billion CNY | 0.57% |
| 2023 Q3 | 1.49 Billion CNY | -4.37% |
| 2023 Q2 | 1.56 Billion CNY | -1.68% |
| 2023 Q1 | 1.59 Billion CNY | 5.09% |
| 2022 Q4 | 1.51 Billion CNY | -0.4% |
| 2022 Q3 | 1.51 Billion CNY | 2.26% |
| 2022 Q2 | 1.48 Billion CNY | 6.66% |
| 2022 Q1 | 1.39 Billion CNY | -0.32% |
| 2022 FY | 1.51 Billion CNY | 8.29% |
| 2021 FY | 1.39 Billion CNY | 3.59% |
| 2021 Q1 | 1.34 Billion CNY | -0.08% |
| 2021 Q4 | 1.39 Billion CNY | 4.25% |
| 2021 Q3 | 1.34 Billion CNY | -3.35% |
| 2021 Q2 | 1.38 Billion CNY | 2.89% |
| 2020 Q3 | 1.24 Billion CNY | -3.58% |
| 2020 Q1 | 1.29 Billion CNY | 0.16% |
| 2020 FY | 1.34 Billion CNY | 4.58% |
| 2020 Q4 | 1.34 Billion CNY | 8.21% |
| 2020 Q2 | 1.29 Billion CNY | 0.08% |
| 2019 Q4 | 1.29 Billion CNY | 340.05% |
| 2019 Q3 | 293.26 Million CNY | -1.86% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 1.29 Billion CNY | 298.92% |
| 2019 Q2 | 298.8 Million CNY | 0.0% |
| 2018 FY | 323.5 Million CNY | 36.05% |
| 2018 Q4 | 323.5 Million CNY | 0.0% |
| 2017 FY | 237.78 Million CNY | 55.38% |
| 2016 FY | 153.03 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Shenzhen Lifotronic Technology Co., Ltd. | 2.33 Billion CNY | 34.696% |